45 Live Notices for Trastuzumab Tenders
Showing 1 to 20
Specific Contract For The Supply Of Exclusive And/Or Infungable Drugs Through The Use Of The Sintel Platform, Pursuant To Art. 55, Paragraph 8 Of Legislative Decree 50/2016, As Part Of The Dynamic Acquisition System Called Aria2020305 "Dynamic Acquisition System For Supplies Of Pharmaceutical Products" - 2Nd Procedure Year 2025
13 Mar 2025
27 Mar 2025Medicines For Biological Therapy
"Delivery Of Medicinal Products For The Needs Of The Medical Oncology Clinic And The Radiation Treatment Clinic Of Debalo" Prof. Ivan Chernozemski Ead.
* Price Collection * Deruxtecan Trastuzumab Medicine, Injectable 100 Mg Bottle, Netupi So Much 300 Mg + Palonosetrona 0.56 Mg Capsula - Civil Clinic
Supply of Medicine and Medical / Surgical equipments : Trastuzumab Injection 440mg in 20ml vial (with\nsolvent)\nTrastuzumab injection 440mg with solvent in 20ml\nvial\nEach 20ml vial to contain 440 mg of Trastuzumab\nwith suitable solvent for intravenous use\nNote:\n1. The product should be stored at 2-8'C\n2. Each vial should be labelled accordingly\n3. The shelf life of the product should be minimum of\n24 months\nPacking : One vial etc .
"Delivery Of Medicinal Products Needed For The Activity Of" Complex Oncology Center - Plovdiv "Eood, Intended For The Treatment Of Oncological Diseases"
Delivery Of Medicinal Products
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv-Region Berlin
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Mecklenburg-Western Pomerania
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Brandenburg
Framework Agreement Of The Trastuzumab Medicine Supply
Frameal Agreement Drug Supply
Delivery Of Medicinal Products Used As Part Of Drug Programs
Drugs For South (012025)
Drugs For Nemcb (082025)
Deruxtecan Concentration: 100 MG Pharmaceutical Form: Injectable Lyophilized Powder; Trastuzumab Composition: Entansine Concentration: 100 MG Pharmaceutical Form: Injectable Lyophilized Powder; Trastuzumab Composition: Entansine Concentration: 160 MG Pharmaceutical Form: Injectable Lyophilized Powder; Crizotinib Concentration*: 250 MG; Enzalutamide Concentration: 40 MG; Ocrelizumab Concentration: 30 MG/ML Pharmaceutical Form: Solution for Infusion; Dapagliflozin Concentration: 10 MG; Evolocumab Concentration: 140 MG/ML Pharmaceutical Form: Injectable Solution Additional: With Applicator Pen; Ruxolitinib Concentration
Specific Contract Within The Dynamic Air Acquisition20305 Acquisition System Aimed At Stipulating Bridge Contracts For The Supply Of Various Drugs
Framework Agreement For Providing Drugs From The National Program Of Oncology And Volume Cost, Pno1.2025 Code For A Period Of 36 Months
Object: Electronic Auction - Acquisition Of Medicines To Meet Court Demands
Frameal Agreement Drug Supply
Tenders by Country